Shattuck Labs News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.10.24	Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline (Benzinga)
01.10.24	Why Is Shattuck Labs Stock Falling In Pre-market? (RTTNews)
27.08.24	Shattuck Labs Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) (Benzinga)
02.08.24	Assessing Shattuck Labs: Insights From 7 Financial Analysts (Benzinga)
14.06.24	Assessing Shattuck Labs: Insights From 6 Financial Analysts (Benzinga)
14.06.24	Shattuck Announces Additional Positive Data From Phase 1B Study Of SL-172154 With Azacitidine (RTTNews)
10.06.24	Shattuck Labs' SL-172154 Granted FDA's Orphan Drug Designation For Treatment Of AML (RTTNews)
21.12.23	Shattuck Labs Prices Public Offering Of 4.7 Mln Shares At $6.45/Share (RTTNews)
13.12.23	Why Is Blood Cancer-Focused Shattuck Labs Stock Soaring Today? (Benzinga)
13.12.23	Shattuck Labs Reports Positive Initial Data From Dose Expansion Trial Of SL-172154 With Azacitidine (RTTNews)
08.11.23	Ausblick: Shattuck Labs legt Quartalsergebnis vor (finanzen.net)
22.02.23	Ausblick: Shattuck Labs präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
07.11.22	Ausblick: Shattuck Labs mit Zahlen zum abgelaufenen Quartal (finanzen.net)
29.03.22	STTK FINAL DEADLINE FRIDAY: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Shattuck Labs, Inc. Investors With Losses In Excess Of $100K To Secure Counsel Before Important April 1 Deadline In Securities... (PR Newswire)
22.03.22	ROSEN, A LEADING LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - STTK (PR Newswire)
13.03.22	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 1 Deadline in Securities Class Action Initiated by the Fir... (PR Newswire)
05.03.22	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - STTK (PR Newswire)
24.02.22	ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - STTK (PR Newswire)
16.02.22	STTK INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the... (PR Newswire)
08.02.22	ROSEN, A TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses Over $100K to Secure Counsel Before Important April 1 Deadline in Securities Class Action Commenced by the Firm -... (PR Newswire)
01.02.22	ROSEN, A TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm -... (PR Newswire)
28.01.22	ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK (PR Newswire)
02.12.21	STTK BREAKING NEWS: ROSEN, A LEADING NATIONAL FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK (PR Newswire)
03.11.20	AUPH's Dry Eye Syndrome Study Fails, KPTI's SEAL Study Hits Goal, REGN Halts Rare Bone Disease Trial (RTTNews)
28.10.20	AUPH Initiates VOCOVID Trial, KALA Gets FDA Nod, NVAX Expands COVID-19 Vaccine Study Size In UK (RTTNews)
27.10.20	ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz (RTTNews)
09.10.20	Shattuck Labs Prices Upsized IPO At $17/Shr, Above The Expected Range (RTTNews)
08.10.20	Healthcare IPOs For October 9 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Shattuck Labs Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten